Jeanne Kehren graduated from the Maisons-Alfort Veterinary School and holds a master in Virology from the Pasteur Institute and a PhD in Immunology from the Paris 7 University.
Jeanne Kehren started her career at Novartis, where she worked in different R&D roles and drove the integration of innovative technologies in drug development. She also fostered the integration of large scale data in pre-clinical and clinical investigations and developed biomarker and stratification approaches across different disease areas. She joined Sanofi in 2009 as Project Director and held successive positions in Product Development across different therapeutic areas, bringing together Commercial, R&D and Industrial Affairs teams on some major development projects. After joining the Global Strategic Development group in charge of products and Franchise investment strategies, she took the lead of the Early Assets group for Diabetes & Cardiovascular and Primary Care working on the reshaping of the portfolio and the development of new businesses. Jeanne joined Bayer on July 1, 2019, heading Digital & Commercial Innovation. As of Feb. 1, 2021 she has been appointed Chief Information Officer Pharmaceuticals in addition to her other responsibilities.
Jeanne is French citizen. She is married and has two children.